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Background
Trimodal age-specific incidence rates for Burkitt lym-
phoma (BL) were observed in the U.S. general popula-
tion, particularly among men. Because BL is AIDS-
related, it is not known whether trimodal incidence
peaks occur independently of immunosuppression. We
therefore investigated age-specific BL incidence in per-
sons with AIDS (PWA).
Methods
Crude and adjusted incidence rates, rate ratios (IRR),
and 95% confidence intervals (95% CI) for BL and other
non-Hodgkin lymphomas (NHLs) diagnosed during 4-
60 months following AIDS diagnosis in the United
States HIV/AIDS Cancer Match study (1980-2005) were
assessed by age and CD4 lymphocyte counts using Pois-
son regression models. Two-tailed p-values < 0.05 were
considered statistically significant.
Findings
We analyzed 306 incident cases (22 cases per 100,000
person-years) diagnosed among 567,865 PWA. The
adjusted incidence rate ratio for BL among males was
1.6 times that among females and among non-Hispa-
nic Blacks 0.4 times that among non-Hispanic Whites,
but it was unrelated to HIV-transmission categories.
The age-specific incidence rates for BL revealed at
least two and perhaps three peaks during the pediatric
and adult/geriatric years, whereas the incidence rates
for other NHLs increased from childhood to adult-
hood. Compared to PWA aged 32-39 years, the
adjusted incidence rate ratio (IRR) for BL was signifi-
cantly elevated among PWA aged 0-19 years (2.3, 95%
CI 1.2-4.4). The adjusted IRR for BL among PWA
aged 20-31 years was significantly decreased (0.6, 95%
CI 0.4-0.8), but the adjusted IRRs for BL among PWA
aged 40-51 years, 52-59 years, and aged 60 years or
older were not significantly different (1.0, 95% CI 0.8-
1.3), (0.8, 95% CI 0.4-1.4), and (1.4, 95% CI 0.7-2.7),
respectively. The risk for BL among PWA with <50
CD4 lymphocytes/µL was 0.3 (95% CI=0.2-0.6) of
those with ≥250 CD4 lymphocytes/µL, whereas the
incidence for other NHLs rose with decreasing CD4
lymphocyte counts.
Interpretation
Our findings strengthen the notion that bi/trimodal BL
may occur independently of immunosuppression. The
deficit of BL at low CD4 lymphocyte counts suggests
that functional CD4 lymphocytes may be required for
BL to develop.
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